Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. chronic disease
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Chronic Disease Articles & Analysis

407 news found

Asthma and Allergy Awareness Month 2025 in Puerto Rico

Asthma and Allergy Awareness Month 2025 in Puerto Rico

The month of May is dedicated to asthma control and education to increase awareness about the disease and how those with it can prevent or mitigate exposures to asthma triggers, allergens, and respiratory irritants. Asthma is one of the most common lifelong chronic diseases in Puerto Rico and across the rest of the United States, according to ...

ByCochrane & Associates, LLC


The Effect of Combined Exercise and Diet on Obese Mice

The Effect of Combined Exercise and Diet on Obese Mice

Such fat accumulation can have serious health consequences, raising the risk of chronic diseases like cardiovascular conditions, diabetes, and some cancers. It is usually associated with a higher prevalence of non-alcoholic fatty liver disease (NAFLD) and asthma. While combining exercise and diet is majorly used as conservative measures in the ...

BySCIREQ - an emka TECHNOLOGIES Company


Protheragen-ING Releases Hundreds of APIs: Anti-Tumor APIs, Hypoglycemic APIs, Antipsychotic APIs, Bronchiectasis APIs, Antihypertensive APIs

Protheragen-ING Releases Hundreds of APIs: Anti-Tumor APIs, Hypoglycemic APIs, Antipsychotic APIs, Bronchiectasis APIs, Antihypertensive APIs

Bronchiectasis APIs for Respiratory Health In respiratory health, Protheragen-ING brings APIs like umeclidinium bromide and vilanterol trifenatate for bronchiectasis, a chronic disease in which bronchi are widened and mucus is not cleared, which results in infection. Bronchodilators and other medicines whose efficacy in clearing the airways and clearing mucus ...

ByProtheragen-ING


Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Chronic Obstructive Pulmonary Disease (COPD) is a global health burden characterized by persistent airflow limitation and progressive lung damage. ...

BySCIREQ - an emka TECHNOLOGIES Company


Ace Therapeutics Releases Diabetic Mouse Models for Preclinical Diabetes Research

Ace Therapeutics Releases Diabetic Mouse Models for Preclinical Diabetes Research

These models have been specifically designed to enable research on different types of diabetes including type 1, type 2, and gestational diabetes, providing valuable insights into disease mechanisms and potential treatment options. Diabetes mellitus is a chronic, systemic, metabolic disease caused by the long-term combination of genetic factors ...

ByAce Therapeutics


AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)

AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)

Providers are under pressure to improve patient outcomes while reducing costs at a time when chronic illness and clinician burnout are on the rise. Despite the transformative potential of digitalization in healthcare, a significant barrier remains. ...

ByInvestorideas.com


Empowering Patient Care: Global Medical Kiosks Market Poised for Remarkable 14.8% CAGR, According to BCC Research

Empowering Patient Care: Global Medical Kiosks Market Poised for Remarkable 14.8% CAGR, According to BCC Research

Boston: “According to the latest BCC Research study, the demand for Medical Kiosks: Global Market and Forecasts is estimated to increase from $1.4 billion in 2022 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 14.8% from 2022 through 2028.” The comprehensive report on the medical kiosks market delivers a thorough analysis of its current landscape and future ...

ByBCC Research


CD Formulation Newly Launches Dissolving Microneedle Preparation Services: Enhancing Drug Delivery Efficiency   

CD Formulation Newly Launches Dissolving Microneedle Preparation Services: Enhancing Drug Delivery Efficiency  

By customizing dissolving microneedles to suit different drug formulations, CD Formulation opens up new possibilities for the treatment of chronic diseases and infectious diseases. The launch of CD Formulation's dissolving microneedle preparation services marks a significant advancement in drug delivery technology. ...

ByCD Formulation


Vantage Welcomes Roczen!

Vantage Welcomes Roczen!

We are delighted to welcome Roczen to the community of healthcare organisations leveraging Vantage Software! We look forward to working together and helping them deliver exceptional care and support to those living with chronic conditions. Book a Free Demo ...

ByVantage Software


Pushing the Boundaries of Drug Delivery: CD Formulation's Breakthrough Microsphere and Microneedle Technologies

Pushing the Boundaries of Drug Delivery: CD Formulation's Breakthrough Microsphere and Microneedle Technologies

These new technologies, including drug half-life extension technologies, injection site drug reservoir technologies, and drug physicochemical enhancement technologies, offer new possibilities in the treatment of many chronic diseases. Microneedle Preparation Technologies In addition to microspheres and long-acting injections, CD Formulation has also made ...

ByCD Formulation


Bayer to start Phase III study with finerenone in adults with chronic kidney disease and type 1 diabetes

Bayer to start Phase III study with finerenone in adults with chronic kidney disease and type 1 diabetes

“Despite progress in risk reduction in type 2 diabetes, chronic kidney disease in type 1 diabetes remains understudied, leaving a huge unmet need to reduce the risks of end-stage kidney disease and cardiovascular events. ...

ByBayer AG


Analysis of the cryolipolysis slimming machine advantages and disadvantages

Analysis of the cryolipolysis slimming machine advantages and disadvantages

Cryolipolysis is a medical aesthetic technique that uses freezing to break down excess fat in the body to achieve a slimming effect. This technique has a great popularity and many people feel confident and beautiful because of the success of this technique to lose weight. As we all know, the medical aesthetic industry has always been a hot industry and cryolipolysis beauty machine as a technique ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


New real world study data on reduced risk of adverse kidney outcomes for Xarelto compared to VKA

New real world study data on reduced risk of adverse kidney outcomes for Xarelto compared to VKA

In the prospective observational XARENO study, after a two year follow up period, Xarelto was associated with a reduced risk of adverse kidney outcomes and all-cause mortality in patients with non-valvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD), compared to vitamin K antagonists (VKA) XARENO evaluated the impact of Xarelto in ...

ByBayer AG


Why Knowledge Is Power In The Treatment Of Obesity

Why Knowledge Is Power In The Treatment Of Obesity

Dr. Ali Tinazli is the CEO of lifespin.health and has 15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP). Obesity rates continue to climb alongside a $254.9 billion global weight loss products and services market. Supplements, smartphone weight loss apps, diet plans and exercise programs are widely available to consumers, yet the World Obesity Federation projects that 1 ...

ByLifespin GmbH


Juvena Therapeutics Bolsters Leadership Team With Key Industry Veterans in Drug Discovery and Development, Data Science, and Business Development

Juvena Therapeutics Bolsters Leadership Team With Key Industry Veterans in Drug Discovery and Development, Data Science, and Business Development

The company plans to continue growing its team to power the expansion of Juvena’s drug discovery platform and advance the company’s biologics pipeline targeting chronic and age-related diseases. "We are thrilled to announce the addition of Neil, Gayathri, Mo and Eddie to the team. ...

ByJuvena Therapeutics, inc.


Kerendia (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes

Kerendia (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes

Kerendia is now indicated for the treatment of chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults. ...

ByBayer AG


Finerenone receives positive CHMP opinion for EU-label extension for broad range of patients with chronic kidney disease and type 2 diabetes

Finerenone receives positive CHMP opinion for EU-label extension for broad range of patients with chronic kidney disease and type 2 diabetes

About Chronic Kidney Disease in Type 2 Diabetes Chronic kidney disease (CKD) is a common and potentially deadly condition that is widely underrecognized. ...

ByBayer AG


Third Pole Therapeutics Receives $32M Strategic Equity Investment to Accelerate its Tankless Inhaled Nitric Oxide (iNO) Platform

Third Pole Therapeutics Receives $32M Strategic Equity Investment to Accelerate its Tankless Inhaled Nitric Oxide (iNO) Platform

It also provides validation that Third Pole’s technology represents the best in class, tankless nitric oxide portable systems to improve acute and chronic cardiopulmonary patient outcomes.” “I am also pleased to report that eNOfit™, our novel miniaturized mobile-wearable nitric oxide device designed to provide ’on-the-go’ treatment for ...

ByThird Pole Therapeutics, Inc.


LISCure`s Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA

LISCure`s Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA

LB-P8 is, to the best of company's knowledge, the first drug to be granted orphan drug designation in the field of microbiome-based treatment for metabolic diseases. The US FDA's ODD program supports the development of treatments for rare diseases with high unmet medical needs and provides various incentives. ...

ByLISCure Biosciences Inc.


Portal Instruments appoints Dr. Veena Rao, PhD, as Chief Business Officer

Portal Instruments appoints Dr. Veena Rao, PhD, as Chief Business Officer

About Portal Instruments Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high ...

ByPortal Instruments, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT